Argatroban for anticoagulation during cardiopulmonary bypass in an infant.

Published

Journal Article

Heparin induced thrombocytopenia (HIT) is a rare, but potentially life-threatening complication of heparin therapy. In patients with HIT, alternative means of anticoagulation are necessary. The authors present an infant with HIT who required anticoagulation during cardiopulmonary bypass for tricuspid valve excision in the treatment of bacterial endocarditis. The direct thrombin inhibitor, argatroban, was successfully used. Previous reports regarding the use of argatroban and other nonheparin anticoagulants for anticoagulation are reviewed and suggestions regarding argatroban dosing in infants are presented.

Full Text

Duke Authors

Cited Authors

  • Dyke, PC; Russo, P; Mureebe, L; Russo, J; Tobias, JD

Published Date

  • April 2005

Published In

Volume / Issue

  • 15 / 4

Start / End Page

  • 328 - 333

PubMed ID

  • 15787926

Pubmed Central ID

  • 15787926

International Standard Serial Number (ISSN)

  • 1155-5645

Digital Object Identifier (DOI)

  • 10.1111/j.1460-9592.2005.01417.x

Language

  • eng

Conference Location

  • France